AR051791A1 - Uso de bloqueantes alfa-adrenergicos para el tratamiento de la dismenorrea - Google Patents

Uso de bloqueantes alfa-adrenergicos para el tratamiento de la dismenorrea

Info

Publication number
AR051791A1
AR051791A1 ARP050105142A ARP050105142A AR051791A1 AR 051791 A1 AR051791 A1 AR 051791A1 AR P050105142 A ARP050105142 A AR P050105142A AR P050105142 A ARP050105142 A AR P050105142A AR 051791 A1 AR051791 A1 AR 051791A1
Authority
AR
Argentina
Prior art keywords
dismenorrea
alfa
treatment
adrenergic blockers
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
ARP050105142A
Other languages
English (en)
Inventor
Davidai Giora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of AR051791A1 publication Critical patent/AR051791A1/es
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un método para tratar la dismenorrea primaria, que comprende administrar a una mujer que la sufre una cantidad terapéuticamente eficaz de un bloqueante alfa-adrenérgico. Los ejemplos de bloqueantes alfa-adrenérgicos son fenoxibenzamina, alfuzosina, doxazosina, tetrazosina, prazosina y tamsulosina, o su éster o sal farmacéuticamente aceptable. Se prefiere el HCl de tamsulosina.
ARP050105142A 2004-12-13 2005-12-09 Uso de bloqueantes alfa-adrenergicos para el tratamiento de la dismenorrea Withdrawn AR051791A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63592504P 2004-12-13 2004-12-13
US72650605P 2005-10-13 2005-10-13

Publications (1)

Publication Number Publication Date
AR051791A1 true AR051791A1 (es) 2007-02-07

Family

ID=36168388

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050105142A Withdrawn AR051791A1 (es) 2004-12-13 2005-12-09 Uso de bloqueantes alfa-adrenergicos para el tratamiento de la dismenorrea

Country Status (7)

Country Link
US (1) US20060128719A1 (es)
EP (1) EP1827404A2 (es)
JP (1) JP2008523143A (es)
AR (1) AR051791A1 (es)
CA (1) CA2588017A1 (es)
TW (1) TW200633692A (es)
WO (1) WO2006065555A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2589700A1 (en) 2004-12-01 2006-07-13 Whitehead Institute For Biomedical Research Modulators of alpha-synuclein toxicity
CA2608198A1 (en) 2005-05-13 2006-11-23 Whitehead Institute For Biomedical Research Modulators of alpha-synuclein toxicity
WO2008073388A2 (en) * 2006-12-11 2008-06-19 Mutual Pharmaceutical Company, Inc. Alfuzosin formulations, methods of making and methods of use
US20100092556A1 (en) * 2006-12-11 2010-04-15 Kristin Arnold Alfuzosin formulations, methods of making, and methods of use
WO2009086306A1 (en) 2007-12-21 2009-07-09 Whitehead Institute For Biomedical Research Modulators of alpha-synuclein toxicity
CA2923476C (en) * 2013-09-06 2021-03-16 The University Of Montana Method of reducing neuronal cell death with haloalkylamines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
CA2104873C (en) * 1991-02-26 2000-05-23 James N. Campbell Compositions and methods of treatment of sympathetically maintained pain
KR100355130B1 (ko) * 1992-09-18 2003-01-30 야마노우치세이야쿠 가부시키가이샤 하이드로겔서방성정제
PT942911E (pt) * 1996-12-06 2002-04-29 Abbott Lab Compostos alfa 1 adrenergicos de benzopiranopirrolo e benzopiranopiridina
US6133275A (en) * 1998-05-06 2000-10-17 Abbott Laboratories 3-phenylpyrrolidine alpha-1 adrenergic compounds
TW536402B (en) * 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
US6376488B1 (en) * 2000-09-07 2002-04-23 Abbott Laboratories Benzoxazine α-1 adrenergic compounds

Also Published As

Publication number Publication date
WO2006065555A2 (en) 2006-06-22
JP2008523143A (ja) 2008-07-03
WO2006065555A3 (en) 2006-08-31
EP1827404A2 (en) 2007-09-05
US20060128719A1 (en) 2006-06-15
CA2588017A1 (en) 2006-06-22
TW200633692A (en) 2006-10-01

Similar Documents

Publication Publication Date Title
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
AR072442A1 (es) Metodo para la terapia del cancer, uso, kit
NO20065148L (no) Monocykliske heterocykler som kinase inhibitorer
EA200970856A1 (ru) Ингибиторы пути хеджхога
EA200970932A1 (ru) Способы лечения с применением пиридопиримидиноновых ингибиторов pi3k альфа
AR051791A1 (es) Uso de bloqueantes alfa-adrenergicos para el tratamiento de la dismenorrea
CR8498A (es) Derivados de prostaglandinas
BRPI0606587A2 (pt) uso de metilnaltrexona e compostos correlatos para tratar disfunção gastrintestinal pós-operatória
ECSP099436A (es) Acilaminopirazoles como inhibidores de fgfr
GT201100181A (es) "inhibidores de proteina cinasa"
EA201201508A1 (ru) Комбинированная терапия
EA200970935A1 (ru) Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа
ECSP055745A (es) Derivados de 1-(4-bencil-piperazin-1-il)-3-fenil-propenona
UY28860A1 (es) Procedimiento para el tratamiento de trastornos premenstruales y otros trastornos sexuales femeninos
EA201500300A1 (ru) Способы применения с-мет-модуляторов
HN2008000949A (es) Derivados de pirimidinil- aril- urea que son inhibidores de fgf
EA200870409A1 (ru) Антагонисты киназы pi3
NO20082907L (no) Fremgangsmate for anvendelse av IL6 antagonister med proteasom-inhibitorer
ECSP077397A (es) Preparación y uso de derivados de ácido bifenil-4-il-carbonilamino para el tratamiento de obesidad
UY28885A1 (es) 4-fenilamino-quinazolin-6-il-amidas referencia cruzada a solicitud(es) relacionada(s)
EA201390766A1 (ru) БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПОЛУЧЕНИЯ
EA201390428A1 (ru) Композиции и способы лечения легочной гипертензии
CR9721A (es) Compuestos de carbamato para utilizar en el tratamiento de desordenes neurodegenerativos
EA201071038A1 (ru) Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
EA202193015A1 (ru) Ингибиторы cdk

Legal Events

Date Code Title Description
FA Abandonment or withdrawal